FDA Unveils New Approval Pathway for Personalized Therapies
FDA launches a new regulatory pathway to approve personalized gene and cell therapies using smaller patient data sets, accelerating access for rare diseases and unmet medical needs.
Nov 12
by Reid Ashton
